Round Table event

Innovation in Life Sciences – CCO round table

Location

London

Date

12th September 2024

Compass Carter Osborne welcomed a cohort of Life Sciences industry leaders to discuss where the next big innovation in the Life Sciences sector is coming from.

Key areas of discussion covered off:

  • Which innovations might have the biggest positive impact on the sector in the next five years
  • Investor standpoint: which technologies are you most likely to invest in, and why?
  • Quantum Computing – hype or hope?
  • What can the Life Sciences sector do to ensure the potential for innovation through computing is delivered?
  • Biotech funding cycle bounce-back
  • Therapeutic or devices in 2025 – target markets

With thanks to guests for their insights and contributions:

  • Geoff Dobson (Discussion Chair)
  • Matthew Fyfe, Storm Therapeutics
  • Prashant Shah, O2h Discovery
  • Dr Iris Good, Plural
  • Jerry Wu, TusPark Holdings
  • Aline Charpentier, Bruntwood SciTech
  • Sebastian Stachowiak, ICE Biopharma
  • Colin Sims, Adthera Bio
  • Dr Suhail Nurbhai, Mission Therapeutics
  • Usman “Oz” Azam, Inspirna
  • Stephen Dowd, Confo Therapeutics
  • Tarquin Bennett-Coles, Compass Carter Osborne
  • Martin Anderson, Carrot Recruitment
  • Alex Boulger, Compass Carter Osborne

Download the full report

Compass Attendees

Tarquin Bennett-Coles - Director, Compass Carter Osborne

Tarquin Bennett-Coles BEd (Hons)

T: 020 8036 3530
E: [email protected]

Geoff Dobson - Non-Executive Advisor to the Board, Compass Carter Osborne

Geoff Dobson cFCIPD

T: 0208 036 3530
E: [email protected]